IN8bio Inc INAB Q1 2026 Earnings EPS Surprise of 63 Highlights Cost Discipline in PreRevenue Biotech ESEA Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase ALNT Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick CPA Q1 2026 Earnings Strong EPS Surprise Despite Flat Stock Reaction AEF Holds Steady at 937 as Market Watches for Direction First Community Bankshares FCBC Holds Steady Near 42 Level Amid Sector Caution Crinetics Pharmaceuticals CRNX Slips 152 as Biotech Sentiment Remains Cautious Ally Financial ALLY Holds Steady Near 43 as Volume Signals Cautious Optimism RDWR Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction